GE HealthCare (Nasdaq:GEHC) announced today that it submitted its CleaRecon DL technology for FDA 510(k) clearance.
GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback